Hyperuricemia is a Risk Factor for One-Year Overall Survival in Elderly Female Patients with Acute Coronary Syndrome

Table 2

Clinical data on admission of patients according to sUA levels.

Clinical data	sUA normal (n = 460)	Hyperuricemia (n = 251)
WBC, 10^9/L (mean ± SD)	7.2 ± 3.2	7.5 ± 3.2	0.252
Hemoglobin, g/L (mean ± SD)	119.3 ± 19.2	113.9 ± 21.6	0.001
Platelets, 10^9/L (mean ± SD)	188.7 ± 64.2	179.0 ± 64.0	0.058
Fasting glucose, mmol/l (median, IQR)	5.9 (4.8–7.6)	5.6 (4.8–6.7)	0.284
HbA1C, % (median, IQR)	6.3 (5.7–6.9)	6.1 (5.6–6.7)	0.313
ALT, U/l (median, IQR)	18.8 (12.8–31.8)	18.8 (12.7–33.3)	0.948
AST, U/l (median, IQR)	22.9 (17.3–53.2)	22.3 (18.1–37.0)	0.955
Albumin, g/l (mean ± SD)	35.1 ± 4.0	35.0 ± 4.6	0.688
Triglycerides, mmol/l (mean ± SD)	1.6 ± 4.1	1.6 ± 1.1	0.901
Total cholesterol, mmol/l (mean ± SD)	3.9 ± 0.9	3.9 ± 1.1	0.365
HDL-cholesterol, mmol/l (mean ± SD)	1.1 ± 0.3	1.0 ± 0.3	0.019
LDL-cholesterol, mmol/l (mean ± SD)	2.3 ± 0.8	2.33 ± 0.9	0.211
Creatinine, μmol/l (mean ± SD)	96.6 ± 68.1	138.0 ± 106.8	<0.001
PT, s (mean ± SD)	13.3 ± 2.5	14.1 ± 4.7	0.117
APTT, s (mean ± SD)	42.3 ± 21.9	36.8 ± 11.9	0.101
CK, U/l (mean ± SD)	350.8 ± 714.9	294.6 ± 524.1	0.561
CK-Mb, U/l (mean ± SD)	42.0 ± 102.8	38.4 ± 104.7	0.681
TnT, pg/ml (median, IQR)	20.1 (11.3–1268.5)	46.7 (12.2–1418.3)	0.365
hs-CRP, mg/l (median, IQR)	4.2 (1.2–23.2)	7.0 (1.8–20.5)	0.173
NT-proBNP, pg/ml (median, IQR)	887.3 (290.0–2656.2)	1704.0 (536.6–5077.2)	<0.001
EF, % (mean ± SD)	54 ± 10.1	52 ± 11.8	0.072

sUA: serum uric acid; WBC: white blood cells; HbA1c: glycated hemoglobin; ALT: alanine aminotransferase; AST: aspartate aminotransferase; HDL: high-density lipoprotein; LDL: low-density lipoprotein; PT: prothrombin time; APTT: activated prothrombin time; CK: creatine kinase; CK-Mb: creatine kinase Mb chain; TnT: troponin T; hs-CRP: high-sensitivity C-reactive protein; NR-proBNP: N-terminal prohormone of brain natriuretic peptide; EF: ejection fraction.